Clinical trial · Observational
Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children
Evaluation of Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children With Early Childhood Caries.
NCT04958005CI-TRIAL-00054590completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to evaluate the levels of interleukin 10, interleukin 6, interleukin 32 and tumor necrosis factor-alpha (TNF-α) in saliva of children with early childhood caries.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early Childhood Caries | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ELISA | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Children with early chilhood caries
- description
- Early chilhood caries group
- interventionNames
- Diagnostic Test: ELISA
- label
- Without early chilhood caries
- description
- Control group
- interventionNames
- Diagnostic Test: ELISA
Primary outcomes (2)
- measure
- IL-32
- timeFrame
- Baseline
- description
- Interleukin- 32 level
- measure
- IL-10
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 70 Months
Show eligibility criteria text
Inclusion Criteria: * Children with untreated early chilhood caries * Age between 3 and 6 years Exclusion Criteria: * Having a systemic problem or mental retardation * Children with treated caries
References
Publications (0)
Data not yet available
No reference posted for this study.